UBS Group’s Medical Action Industries MDCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
– Sell
-3,563
Closed -$50K – 11010
2014
Q3
$50K Sell
3,563
-17,037
-83% -$235K ﹤0.01% 6843
2014
Q2
$282K Buy
20,600
+18,675
+970% +$135K ﹤0.01% 4816
2014
Q1
$13K Hold
1,925
– – ﹤0.01% 8657
2013
Q4
$16K Sell
1,925
-710
-27% -$5.12K ﹤0.01% 8475
2013
Q3
$18K Buy
2,635
+710
+37% +$5K ﹤0.01% 8232
2013
Q2
$15K Hold
1,925
– – ﹤0.01% 8249

UBS Group's MDCI Position: Q4 2014 in Review

UBS Group sold out of Medical Action Industries (MDCI) in Q4 2014, closing a stake of 3,563 shares — an estimated $50K sold.

UBS Group first reported a position in MDCI in Q2 2013 and held it in 6 quarters. The position peaked at $282K in Q2 2014. 0 funds tracked by Wall St. Rank hold MDCI as of Q4 2014.

  • UBS Group reported no remaining Medical Action Industries position as of Q4 2014 after selling out during the quarter.
  • UBS Group sold 3,563 Medical Action Industries shares in Q4 2014, an estimated $50K.
  • UBS Group first reported a position in Medical Action Industries in Q2 2013 and held it in 6 quarters.
  • UBS Group's Medical Action Industries position peaked at $282K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held Medical Action Industries as of Q4 2014.

Based on UBS Group's 13F filing for Q4 2014, filed 17 Feb 2015.